A Long-Acting Human Growth Hormone (Nutropin Depot®): Efficacy and Safety Following Two Years of Treatment in Children with Growth Hormone Deficiency

Artikel in diesem Heft

1. TABLE OF CONTENTS
2. Introduction
3. Childhood Brain Tumors
4. Use of Magnetic Resonance Imaging in Short Stature: Data from National Cooperative Growth Study (NCGS) Substudy 8
5. Utility of Magnetic Resonance Imaging in the Evaluation of the Child with Central Diabetes Insipidus
6. Characteristics of Growth Hormone Therapy for Pediatric Patients with Brain Tumors in the National Cooperative Growth Study (NCGS) and from a Survey of Pediatric Endocrinologists
7. Septo-Optic Dysplasia/Optic Nerve Hypoplasia: Data from the National Cooperative Growth Study (NCGS)
8. Genetic Disorders of Human Growth
9. A Long-Acting Human Growth Hormone (Nutropin Depot®): Efficacy and Safety Following Two Years of Treatment in Children with Growth Hormone Deficiency
10. Growth Hormone Treatment and Pseudotumor Cerebri: Coincidence or Close Relationship?
11. Growth Problems and Growth Hormone Treatment in Children with Cystic Fibrosis
12. Type 2 Diabetes Mellitus in Children and Youth: A New Epidemic
13. Progress in the Treatment of Childhood Diabetes Mellitus and Obesity
14. Exercise, Diet, and Childhood Obesity: The GH-IGF-I Connection